Fasting APO B48 levels are associated with microalbuminuria in patients with type 2 diabetes

E Lapice1, P Cipriano, L Patti

  • 1Department of Clinical and Experimental Medicine, University of Naples Federico II, Italy. emanuela1978@hotmail.it

Acta Diabetologica
|March 21, 2012
PubMed

Insights

Microalbuminuria in type 2 diabetes is linked to higher Apo B48 levels, a marker of atherogenic lipoproteins. This association may explain increased cardiovascular risk in these patients.

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Nephrology

Background:

  • Type 2 diabetes mellitus (T2DM) patients with microalbuminuria face high macrovascular disease risk.
  • Microalbuminuria indicates early kidney damage and is a marker for cardiovascular complications.
  • Apolipoprotein B48 (Apo B48) is a marker for intestinally derived triglyceride-rich lipoproteins (TRLs), considered highly atherogenic.

Purpose of the Study:

  • To investigate the association between microalbuminuria and fasting plasma Apo B48 levels in T2DM patients.
  • To determine if Apo B48 levels are an independent risk factor for microalbuminuria in T2DM.
  • To explore the potential role of elevated Apo B48 in the excess cardiovascular risk observed in T2DM patients with microalbuminuria.

Main Methods:

  • A study involving 50 T2DM patients (aged 35-75) without overt macrovascular disease or nephropathy.
  • Measurements included anthropometry, fasting plasma lipids, HbA1c, creatinine, estimated GFR, and urinary albumin/creatinine ratio.
  • Fasting plasma Apo B48 levels were quantified using ELISA.

Main Results:

  • Patients with microalbuminuria exhibited significantly higher fasting Apo B48 levels compared to those without (1.765 ± 1.379 μg/ml vs. 1.022 ± 0.692 μg/ml, p = 0.01).
  • Microalbuminuria was associated with longer diabetes duration (borderline significance).
  • Multivariate logistic regression confirmed that elevated Apo B48 levels were significantly associated with microalbuminuria, independent of major confounders.

Conclusions:

  • Microalbuminuria in T2DM patients is independently associated with elevated fasting Apo B48 levels.
  • Increased Apo B48 may contribute to the heightened cardiovascular risk in T2DM patients with microalbuminuria.
  • Targeting Apo B48-containing lipoproteins could be a strategy to mitigate cardiovascular risk in this population.

Related Concept Videos

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...